Aurobindo Pharma Limited 7/23/2018 Chemistry support for building partnerships CTX LIFESCIENCES PVT LTD An integrated Partner throughout API Cycle US FDA/EU GMP Certified/PMDA Accreditation and compliant www.aurobindo.com

Aurobindo Pharma Limited 7/23/2018 Who we are Colourtex, a 40-year old largest dyes and intermediates company in India with over 2000 employees and annual revenues of USD 250 millions, diversified into Pharmaceuticals in 2004 Privately held Company headquartered in Surat, 260 kms north of Mumbai. Surat - a major hub for Chemicals and Diamonds Commercial production started in the state-of-the-art green-field facility during second quarter of 2006 Presence in anti-infectives, CVS, CNS, anti-diabetes and other segments www.aurobindo.com

Aurobindo Pharma Limited 7/23/2018 Our Vision To be the preferred strategic partner for the pharmaceutical industry and share responsibilities & goals for the enhancement of human health. www.aurobindo.com

Aurobindo Pharma Limited 7/23/2018 Our Mission To develop and manufacture Active Pharmaceutical Ingredients and Intermediates for global supply complying to quality and regulatory requirements of our customers. www.aurobindo.com

Aurobindo Pharma Limited 7/23/2018 Our Mfg Strengths and Plans US FDA inspected and compliant facility, EUGMP Certified andJapan Accredited with over 200,000 sq.ft area spread on 38 acres of land. One facility for all markets. Large intermediate plant. Cost effective operating structure with vertical integration in some products Skilled workforce and competent technical & management team with global and global pharma experience Total number of reactors : 83 Nos. Total reactors volume : 220 meter cube Total number of people : 296 www.aurobindo.com

Aurobindo Pharma Limited 7/23/2018 Our Mfg Strengths and Plans Access to own large infrastructure, viz. water reservoirs, power generation, effluent treatment plant, landfill site and incinerators. Also, large intermediate plant Can handle complex chemical reactions viz., cynation, nitration, chlorosulfonation, hydrogenation and ethoxylation Investment over USD 27 millions US DMF filed for 16 products and three approved. CEP filed for 9 products and seven approved. Validations completed for Olmesartan and Pregabalin and planned for Candesartan and Quetiapine www.aurobindo.com

Aurobindo Pharma Limited 7/23/2018 Product Range Amiodarone Alendronate Sodium Acetazolamide Carvedilol Chlorothiazide Carbamazepine Hydrochlorothiazide Irbesartan Lamotrigine Metoprolol Tartrate/Succinate Olmesartan Oxcarbazepine Oxymetazoline/Xylometazoline Pregabalin Terbinafine Terazosin Sevelamer Hcl Colesevelam Candesartan www.aurobindo.com

Why partner with CTX Lifesciences Aurobindo Pharma Limited 7/23/2018 Why partner with CTX Lifesciences Chemistry competence over thirty years Excellent infrastructure viz. water, power, disposal of gaseous, liquid and solid organic wastes and financial strength cGMP compliant state of the art facility with focus on API and Intermediates. Facility audited by Astra Zeneca, Glaxo, Novartis, EMerck, Aventis,, Teva, Mylan, Sandoz, Actavis, Siegfried, Pliva and visit by Pfizer and found to comply their requirements. US FDA inspected and compliant facility; PMDA accreditation and EUGMP Certified. Plan to file at least 5 DMFs in 2012 Experienced technical and commercial team with global and global pharma experience. Vertical integration on Hydrochlorothiazide, Xylometazoline, Oxymetazoline, Irbesartan Sevelamer, Colesevalam, and Lamotrigine and working on Metoprolol Tartrate, Succinate and Oxcarbazepine Environment, Safety and Health Practices www.aurobindo.com

Aurobindo Pharma Limited 7/23/2018 Manufacturing and R&D www.aurobindo.com

Aurobindo Pharma Limited 7/23/2018 Thank You www.aurobindo.com